[HTML][HTML] The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine …
A Volkmann, AL Williamson, H Weidenthaler… - Vaccine, 2021 - Elsevier
Abstract The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)
was formed to evaluate the safety and characteristics of live, recombinant viral vector …
was formed to evaluate the safety and characteristics of live, recombinant viral vector …
Replication-inducible vaccinia virus vectors with enhanced safety in vivo
CM O'Connell, B Jasperse, CJ Hagen, A Titong… - PLoS …, 2020 - journals.plos.org
Vaccinia virus (VACV) has been used extensively as the vaccine against smallpox and as a
viral vector for the development of recombinant vaccines and cancer therapies. Replication …
viral vector for the development of recombinant vaccines and cancer therapies. Replication …
Genital Autoinoculation with Vaccinia: A Look at Two Cases
JR Whittington, NL Rollene, RS Gist - Military Medicine, 2018 - academic.oup.com
Introduction Smallpox, or vaccinia, has been eradicated worldwide as a disease; however, it
may be weaponized and is thus a required immunization when military members deploy to …
may be weaponized and is thus a required immunization when military members deploy to …
[PDF][PDF] Risk Assessment and Risk Management Plan
R Plan, FM Critical - 2019 - adb.org
M The capacity of agencies to implement the action plan to prevent and mitigate the impact
of global COVID-19 related potential risks to the national economy may be constrained by …
of global COVID-19 related potential risks to the national economy may be constrained by …
[引用][C] Trial of genetically modified vaccines against Ross River virus infection in horses Applicant–The University of Queensland
LAN DIR